-
Pesquisa publicada na revista científica eLife concluiu ser possível calcular a proporção da população previamente infectada (soroprevalência) por SARS-CoV-2 utilizando amostras de doadores de banco de sangue. Com os resultados, além de montar uma espécie de “retrato” da epidemia de Covid-19 no Brasil durante o primeiro ano, os pesquisadores apontam que a nova metodologia pode ser aplicada para rastrear outros tipos de [...]
-
En el marco de una investigación publicada en la revista científica eLife, se arribó a la conclusión de que es posible calcular la proporción de la población previamente infectada (seroprevalencia) con el SARS-CoV-2 mediante la utilización de muestras de donantes de bancos de sangre. Con estos resultados, aparte de montar una especie de “retrato” de la epidemia de COVID-19 en Brasil durante su primer año, los científicos [...]
-
An article published in the journal eLife reports a study in which researchers concluded that the proportion of the population previously infected by SARS-CoV-2 (infection-induced seroprevalence) can be estimated using blood donation samples. The findings offer a sort of “portrait” of the first year of the COVID-19 epidemic in Brazil. According to the authors, their novel methodology can also be used to track and estimate collective immunity to other infectious [...]
-
The proportion of the population previously infected by SARS-CoV-2 (infection-induced seroprevalence) can be estimated using blood donation samples, according to a new study published in the journal eLife. The findings offer a sort of portrait of the first year of the COVID-19 epidemic in Brazil.
The usual method of estimating seroprevalence in Brazil is based on random samples of the population. This method is costly and hard to perform periodically in real-time. Serosurveillance is [...]
-
发表在《eLife》杂志上的一篇文章报道了一项研究，研究人员在该研究中得出结论，可以使用献血样本估计以前感染SARS-CoV-2的人口比例(感染诱导血清流行率)。这些发现为巴西COVID-19流行的第一年提供了一种“画像”。根据作者的说法，他们的新方法也可以用来跟踪和估计对其他传染病的集体免疫力。
在巴西，估计血清流行率的常用方法是基于人群的随机样本。作者指 [...]
-
An article published in the journal eLife reports a study in which researchers concluded that the proportion of the population previously infected by SARS-CoV-2 (infection-induced seroprevalence) can be estimated using blood donation samples. The findings offer a sort of “portrait” of the first year of the COVID-19 epidemic in Brazil. According to the authors, their novel methodology can also be used to track and estimate collective immunity to other infectious [...]
-
by Luciana Constantino, FAPESP
An article published in the journal eLife reports a study in which researchers conclude that the proportion of the population previously infected by SARS-CoV-2 (infection-induced seroprevalence) can be estimated using blood donation samples. The findings offer a sort of "portrait" of the first year of the COVID-19 epidemic in Brazil. According to the authors, their novel methodology can also be used to track and estimate collective immunity to other [...]
-
Ein Artikel veröffentlicht im Tagebuch eLife berichtet eine Studie, in der Forscher zu dem Schluss kamen, dass der Anteil der Bevölkerung, der zuvor mit SARS-CoV-2 infiziert war (infektionsinduzierte Seroprävalenz), anhand von Blutspendeproben geschätzt werden kann. Die Ergebnisse bieten eine Art „Porträt“ des ersten Jahres der COVID-19-Epidemie in Brasilien. Laut den Autoren kann ihre neuartige Methodik auch verwendet werden, um die kollektive [...]
-
A group of researchers in Brazil and the UK have developed a method to track seroprevalence in real time. An article in the journal eLife shows how this was done in the case of SARS-CoV-2, providing a "portrait" of the first year of COVID-19 in Brazil.
An article published in the journal eLife reports a study in which researchers concluded that the proportion of the population previously infected by SARS-CoV-2 (infection-induced seroprevalence) can be estimated using blood donation [...]
-
An article published in the journal eLife reports a study in which researchers concluded that the proportion of the population previously infected by
SARS-CoV-2 (infection-induced seroprevalence) can be estimated using blood donation samples. The findings offer a sort of "portrait" of the first year of the COVID-19 epidemic in Brazil. According to the authors, their novel methodology can also be used to track and estimate collective immunity to other infectious diseases. The usual [...]
